Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Intraday Session

Author: Benzinga Insights | December 13, 2022 01:31pm

Gainers

  • OpGen (NASDAQ:OPGN) stock increased by 242.3% to $0.43 during Tuesday's regular session. OpGen's stock is trading at a volume of 169.2 million shares as of 12:30 EST. This is 40400.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $22.9 million.
  • BeyondSpring (NASDAQ:BYSI) shares rose 30.65% to $0.99. Trading volume for BeyondSpring's stock is 3.2 million as of 12:30 EST. This is 2800.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $38.5 million.
  • 180 Life Sciences (NASDAQ:ATNF) stock increased by 22.99% to $0.33. The current volume of 156.3K shares is 77.7% of 180 Life Sciences's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $13.3 million.
  • WAVE Life Sciences (NASDAQ:WVE) shares increased by 22.99% to $4.44. As of 12:30 EST, this security is trading at a volume of 3.5 million shares, making up 946.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $385.8 million.
  • Moderna (NASDAQ:MRNA) stock rose 22.5% to $202.3. The current volume of 17.1 million shares is 365.8% of Moderna's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $77.7 billion.
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) shares increased by 22.26% to $3.13. The current volume of 1.1 million shares is 49.4% of Shuttle Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $42.3 million.

Losers

  • Quotient (NASDAQ:QTNT) stock declined by 48.9% to $0.35 during Tuesday's regular session. Trading volume for Quotient's stock is 1.3 million as of 12:30 EST. This is 898.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.2 million.
  • Midatech Pharma (NASDAQ:MTP) stock fell 29.18% to $1.17. As of 12:30 EST, this security is trading at a volume of 93.8K shares, making up 386.1% of its average full-day volume over the last 100 days. The company's market cap stands at $4.6 million.
  • Clovis Oncology (NASDAQ:CLVS) stock decreased by 25.27% to $0.15. The current volume of 9.0 million shares is 198.6% of Clovis Oncology's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $21.8 million.
  • Healthcare Triangle (NASDAQ:HCTI) stock decreased by 24.78% to $0.27. Trading volume for this security as of 12:30 EST is 10.7 million, which is 589.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $11.0 million.
  • Harpoon Therapeutics (NASDAQ:HARP) shares decreased by 23.41% to $1.08. Trading volume for Harpoon Therapeutics's stock is 3.3 million as of 12:30 EST. This is 195.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $35.8 million.
  • Vanda Pharma (NASDAQ:VNDA) stock declined by 23.19% to $8.29. Trading volume for this security as of 12:30 EST is 1.3 million, which is 367.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $469.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ATNF BYSI CLVS HARP HCTI MRNA MTP OPGN QTNT SHPH VNDA WVE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist